-
Economic Analysis of the Causes of Drug Shortages
-
Additional Information FDA Report: "A Review of FDA's Approach to Medical Product Shortages"
About This Issue Brief Drug shortages have been having significant impacts on patients and healthcare providers. In order to understand what is causing drug shortages and to enable evaluation of potential solutions, ASPE conducted an analysis of the underlying factors that lead to periods of shortage in the prescription drug market. This report complements the FDA’s report on the current drug shortage problem, which focuses on the FDA’s role in monitoring and responding to shortages. The Issue Brief was written by Kevin Haninger, Amber Jessup, and Kathleen Koehler of ASPE’s Office of Science and Data Policy. Sherry Glied, PhD
Assistant SecretaryLaina Bush
Associate Deputy Assistant Secretary for Science and Data Policy -
Summary
-
Background
-
Magnitude and Timing of the Problem
-
Why are Shortages a Feature of the Prescription Drug Market?
-
Sterile Injectable Oncology Drugs Market - Demand and Supply
-
Sterile Injectable Oncology Drugs Market - Prices and Volumes
-
Sterile Injectable Drugs - Changes in Market Structure
-
Supply Disruptions
-
Framework for Strategies to Reduce Shortages
-
Recommendations
-
Methods
-
Appendix A: Drug Shortages Followed by the University of Utah DIS.
-
Appendix B: Dataset of Average Sales Prices
-
Endnotes
-
"ib.pdf" (pdf, 551.61Kb)
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®
